Product Overview: Enmast-LC Tablets by Solvista Healthcare
Enmast-LC Tablets is a high-potency pharmaceutical formulation developed by Solvista Healthcare, specifically designed to provide “Advanced Allergy & Respiratory Relief.” The product combines two synergistic active ingredients—Montelukast Sodium and Levocetirizine Hydrochloride—to offer a comprehensive solution for patients suffering from allergic rhinitis and associated respiratory complications.
1. Pharmaceutical Composition
The efficacy of Enmast-LC lies in its dual-component formula, adhering to Indian Pharmacopoeia (IP) standards:
- Montelukast Sodium: A selective leukotriene receptor antagonist. Leukotrienes are chemicals the body releases when breathing in an allergen (such as pollen). They cause swelling in the lungs and tightening of the muscles around the airways. Montelukast blocks these leukotrienes to improve symptoms and prevent breathing difficulties.
- Levocetirizine Hydrochloride: A third-generation non-sedative antihistamine. It works by blocking histamine, a natural substance in the body that causes allergic reactions. It is particularly effective at reducing symptoms like watery eyes, runny nose, and itching.
2. Key Indications and Benefits
As highlighted in the product’s clinical profile, Enmast-LC is indicated for the treatment of allergic rhinitis (both seasonal and perennial) and associated respiratory allergic symptoms. Its primary benefits include:
- Dual-Action Formula: By targeting both the histamine and leukotriene pathways, the tablet provides more robust relief than single-ingredient antihistamines.
- 24-Hour Symptom Control: Designed for long-lasting efficacy, a single dose typically provides a full day of relief from persistent allergy triggers.
- Respiratory Comfort: It is specifically effective at reducing sneezing, nasal congestion, and the “stuffy” feeling often associated with chronic allergies.
- Quality Assurance: The product is manufactured under strict quality controls, backed by WHO-GMP Certified, ISO Certified, and general Quality Assured seals, ensuring that every batch meets international safety and purity standards.
3. Mechanism of Action
When an allergen enters the system, the body initiates an inflammatory response. Levocetirizine acts as the “first responder,” quickly blocking histamine receptors to stop the immediate itch and sneeze. Simultaneously, Montelukast works on a deeper level to prevent the late-phase inflammatory response, which is responsible for nasal congestion and airway narrowing. This two-pronged approach makes it highly effective for patients who do not find sufficient relief from standard antihistamines alone.
4. Packaging and Administration
Enmast-LC is presented in a professional 10 x 10 tablet blister pack (as seen in the provided image), ensuring convenient storage and dosage tracking for the patient.
- Dosage: While typically prescribed as one tablet daily, patients must follow the specific guidance of a healthcare professional.
- Safety: The non-sedative nature of Levocetirizine makes it a preferred choice for daytime use compared to older antihistamines, though individual sensitivity may vary.
